Hyperparathyroidism is augmented by ovariectomy in Nagase analbuminemic rats.

The role of albumin in bone metabolism was studied in Nagase analbuminemic (NA) rats. Serum calcium (Ca), inorganic phosphate (Pi) and magnesium (Mg) concentrations did not differ between female NA and control Sprague-Dawley (SD) rats at the time of ovariectomy (ovx), although serum ionized Ca was significantly lower in NA rats than in SD rats. Serum parathyroid hormone (PTH) and osteocalcin (OC) concentrations and urinary Ca excretion were significantly greater in NA rats than in SD rats, suggesting hyperparathyroidism and the resultant enhanced bone turnover in NA rats. Paradoxically, ovx increased serum PTH and OC in NA rats but not in SD rats. Ovx-induced exacerbation of hyperparathyroidism was confirmed by significantly greater conversion of 25-hydroxyvitamin D to 1, 25-dihydroxyvitamin D in ovx NA rats even after normalization to vitamin D-binding protein. Bone mineral density (BMD) in proximal tibia increased similarly in a time-dependent manner in sham-operated NA and SD rats. However, ovx ablated the time-dependent increase of BMD in SD rats and significantly decreased BMD in NA rats by 2 wk after ovx, resulting in a significantly lower BMD in ovx NA rats than in ovx SD rats. In summary, NA rats, which are analbuminemic with compensatory increases in lipid and protein synthesis, developed hyperparathyroidism, possibly due to an increase in serum Pi and a reduction of ionized Ca, and ovx induced a greater BMD reduction in NA rats than in SD rats, probably by exacerbating hyperparathyroidism.

[1]  S. Otani,et al.  Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. , 1999, Metabolism: clinical and experimental.

[2]  L. Niskanen,et al.  Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Masaaki Takahashi,et al.  Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time , 1999, Clinical endocrinology.

[4]  J. Joles,et al.  Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. , 1997, Kidney international.

[5]  M. Inaba,et al.  Positive correlation between levels of IL-1 or IL-2 and 1,25(OH)2D/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritis. , 1997, Life sciences.

[6]  E. Kallee.  Bennhold's analbuminemia: a follow-up study of the first two cases (1953-1992). , 1996, The Journal of laboratory and clinical medicine.

[7]  G. Russell,et al.  Spontaneous release of interleukin-I and interleukin-6 by peripheral blood mononuclear cells after oophorectomy. , 1992, Clinical science.

[8]  H. Rico,et al.  Crush fracture syndrome in senile osteoporosis: A nutritional consequence? , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  E. Slatopolsky,et al.  A new sensitive homologous radioimmunoassay for amino‐terminal parathyroid hormone in the rat , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  H. DeLuca,et al.  Characteristics of the 25-hydroxyvitamin D3- and 1,25-dihydroxyvitamin D3-24-hydroxylase(s) from HL-60 cells. , 1991, Archives of biochemistry and biophysics.

[11]  S. Polberger,et al.  Eleven plasma proteins as indicators of protein nutritional status in very low birth weight infants. , 1990, Pediatrics.

[12]  J. Verhaeghe,et al.  Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. , 1989, Endocrinology.

[13]  D. Bikle,et al.  Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. , 1989, Endocrinology.

[14]  H. DeLuca,et al.  Stabilization of 1,25-dihydroxyvitamin D-3 receptor in the human leukemia cell line, HL-60, with diisopropylfluorophosphate. , 1989, Biochimica et biophysica acta.

[15]  T. Wronski,et al.  Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. , 1988, Endocrinology.

[16]  P. E. Gibbs,et al.  Origin of structural domains of the serum-albumin gene family and a predicted structure of the gene for vitamin D-binding protein. , 1987, Molecular biology and evolution.

[17]  R. Craig.  Serum albumin as a nutritional marker. , 1987, Annals of internal medicine.

[18]  R. Tuimala,et al.  Vitamin D deficiency in women with femoral neck fracture. , 1986, Maturitas.

[19]  W. Woloszczuk.  Determination of vitamin D binding protein by Scatchard analysis and estimation of a free 25-hydroxy-vitamin D index. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[20]  Z. Varghese,et al.  Dissociation between calcium and phosphate absorption in nephrotic syndrome. , 1983, Clinical science.

[21]  T. Sugimura,et al.  Presence of albumin mRNA precursors in nuclei of analbuminemic rat liver lacking cytoplasmic albumin mRNA. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Nagase,et al.  Albumin-deficient rat mutant. , 1979, Science.

[23]  J. McDonald,et al.  Relationship of free and total calcium in hypercalcemic conditions. , 1979, The Journal of clinical endocrinology and metabolism.

[24]  D. Morgan,et al.  Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. , 1979, Journal of clinical pathology.

[25]  L. Wilkins.  Voluntary Medical Care Insurance in the United States , 1949 .

[26]  F. Albright,et al.  POSTMENOPAUSAL OSTEOPOROSIS: ITS CLINICAL FEATURES , 1941 .

[27]  J. B. Collip,et al.  THE PARATHYROID GLANDS , 1932 .

[28]  G. Kaysen,et al.  Serum alpha 2-macroglobulin and alpha 1-inhibitor 3 concentrations are increased in hypoalbuminemia by post-transcriptional mechanisms. , 1998, Kidney international.

[29]  G. Kaysen,et al.  Serum α2-macroglobulin and α1-inhibitor 3 concentrations are increased in hypoalbuminemia by post-transcriptional mechanisms , 1998 .

[30]  M. Costanza,et al.  Importance of Albumin, 25(OH)-Vitamin D and IGFBP-3 as Risk Factors in Elderly Women and Men with Hip Fracture , 1997, Osteoporosis International.

[31]  G. Kaysen.  Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis. , 1992, Mineral and Electrolyte Metabolism.

[32]  E. Ogata,et al.  Circulating bone Gla protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay. , 1991, Contributions to nephrology.

[33]  J. Lacy.  Albumin overview: use as a nutritional marker and as a therapeutic intervention. , 1991, Critical care nurse.

[34]  C. Cooper,et al.  Indices of calcium metabolism in women with hip fractures. , 1989, Bone and mineral.

[35]  A. Parfitt,et al.  Bone remodeling. , 1988, Henry Ford Hospital medical journal.

[36]  K. Kusumi,et al.  Plasma lipid concentrations and enzyme activities in Nagase analbuminemia rats (NAR). , 1983, Jikken dobutsu. Experimental animals.

[37]  R. Eliakim,et al.  [Postmenopausal osteoporosis]. , 1983, Harefuah.

[38]  F. Albright,et al.  The Parathyriod Glands and Metabolic Bone Disease. , 1948 .